FUJIFILM Holdings Corp
Capital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.Company Description
- CEO
- Teiichi Goto
- Full Time Employees
- 73,526
- Sector
- Health technology
- Industry
- Medical specialties
- Address
- 7-3, Akasaka 9-chome Tokyo TY Japan 107-0052
- IPO Date
- May 16, 1949
- Website
- fujifilmholdings.com
- Similar Companies
- Business
- FUJIFILM Holdings Corporation operates as a diversified global technology company primarily engaged in the development, manufacture, and sale of products and services across four key business segments: healthcare, electronics, business innovation, and imaging. Its healthcare segment offers a comprehensive range of products and services including medical devices, bio CDMO (Biomedical Contract Development and Manufacturing Organization) services, pharmaceuticals, regenerative medicine, and life sciences products such as cosmetics and supplements. The electronics segment focuses on materials for industrial applications including display and touch panels, semiconductors and image sensors, functional films, and storage media solutions. The business innovation segment provides document solutions, system integration, cloud services, business process outsourcing, office equipment such as multifunction devices and printers, as well as high-volume printing solutions for graphic communications and production print environments. The imaging segment encompasses photographic films, digital cameras (notably the X Series of mirrorless cameras), instant cameras, developing and printing systems, color paper, photo printing services, and various optical devices including TV, cinema, and industrial lenses. FUJIFILM operates globally, with a significant presence in Japan, Asia, the Americas, and Europe, employing over 70,000 people worldwide. The company was founded in 1934 and is headquartered in Tokyo, Japan. Recent strategic developments include the completion of a new building for advanced semiconductor materials in Shizuoka, Japan, enhancing its electronics materials capabilities. FUJIFILM has expanded its healthcare portfolio through joint research initiatives, including with the National Cancer Center to advance innovative cancer treatment technologies. The company has also launched new health screening centers in four ASEAN countries—Vietnam, Thailand, the Philippines, and Malaysia—broadening its healthcare service footprint. It continues to innovate in medical imaging, highlighted by advancements in AI utilization, speed, and automation within its Synapse enterprise imaging portfolio. Notably, FUJIFILM acquired Hitachi’s diagnostic imaging business in 2021 to reinforce its healthcare segment, and it recently completed the acquisition of a dedicated cell therapy manufacturing facility from Atara Biotherapeutics, expanding its advanced therapies CDMO business. Moreover, it acquired Kalon Biotherapeutics in 2024, enhancing its vaccine manufacturing capacity. Under its medium-term management plan VISION2030, FUJIFILM is targeting global revenue growth and continued transformation into a value-creating enterprise across its core technologies and markets. The company serves diverse customer bases including healthcare providers, industrial manufacturers, businesses requiring document and printing solutions, and consumers in the imaging and photography markets. Its integrated technological expertise, broad product portfolio, and ongoing strategic investments support its leadership position in the healthcare and imaging sectors as well as its expanding role in electronics and business innovation services. FUJIFILM Holdings Corporation is a key player in global technology and innovation with a strong commitment to social impact and sustainability.
Company News
Fujifilm Announces Global Strategic Partnership With ePac Flexible Packaging
Fujifilm Expands Bronchoscopy Portfolio With Two New 800 Series Bronchoscopes at CHEST 2026 Annual Meeting
Fujifilm Introduces FUJIFILM HX1024 Printbar System
Fujifilm's instax mini Evo Cinema™ Named One of TIME's Best Inventions of 2026
Capture What Shapes You - Fujifilm Introduces instax SQUARE 2™ instant camera
Fujifilm (OTCMKTS:FUJIY) Shares Gap Down – Should You Sell?
Fujifilm Holdings Corp. (OTCMKTS:FUJIY) Stock Short Interest Report for September
Fujifilm to Showcase U.S. Manufacturing and One-Stop Solution Strategy at SEMICON West 2026
Fujifilm Announces First Install of its FUJIFILM REVORIA PRESS™ PC2120 in the Americas at National Color Graphics
Fujifilm: Turning Bullish With Business Sale And Planned Spin-Off (Rating Upgrade)
Fujifilm Expands Consumer Photo Printing Capabilities with the Introduction of “Fujifilm for Google Photos Print Store”
Fujifilm Holdings Corp. (OTCMKTS:FUJIY) Shares Shorted: Short Interest Down 60.0% in September
All You Need to Know About Fujifilm (FUJIY) Rating Upgrade to Buy
FUJIFILM Business Innovation Recognizes 42 Global Achievements in Print Excellence at the Innovation Print Awards 2026 Global
A Camera That Fits With You: Fujifilm Introduces instax Pal 2™ Digital Camera
Memories, Printed WIDE - Fujifilm Introduces instax Link WIDE 2™ Smartphone Printer
Fujifilm Launches ETERNA ProRemote, Remote Control App for FUJIFILM GFX ETERNA 55 Filmmaking Camera
Fujifilm Announces Availability of FUJINON UA94x8.7BESM 4K Broadcast Zoom Lens
Fujifilm Expands Consumer Photo Printing Capabilities with the Introduction of “Fujifilm for Google Photos Print Store”
Fujifilm Announces First Sale of its FUJIFILM J Press FP790 Flexible Packaging Press in the Americas to Quantum Flex Pack